3 Small Biotech Stocks Being Run by Proven Winners

3 Small Biotech Stocks Being Run by Proven Winners

Great leaders are important in any industry, but perhaps they're even more valuable in biotech, where any number of clinical-stage and regulatory obstacles can derail drug research and send share prices reeling. For that reason, investing in biotech stocks such as Aurinia Pharmaceuticals (NASDAQ: AUPH), Axovant Sciences (NYSE: AXON), and Esperion Therapeutics (NASDAQ: ESPR) -- all of which are run by proven leaders -- could be savvy.

Aurinia Pharmaceuticals' C-suite is packed with ex-Aspreva Pharmaceuticals executives who know a thing or two about lupus nephritis (LN).

IMAGE SOURCE: GETTY IMAGES.

Continue reading

Source: Fool.com